Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-11

Clinical Trial Update: Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating DiaPep277 in Type 1 Diabetes has completed and reports on long-term treatment effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DiaPep277 (DiaPep277)

Snippet

Sponsor: Andromeda Biotech Ltd. | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED